Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | References | |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | References | |
Homo sapiens | dopamine receptor D3 | References | |
Homo sapiens | potassium voltage-gated channel, subfamily H (eag-related), member 2 | References | |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 19 | References | |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | References | |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | References | |
Homo sapiens | dopamine receptor D2 | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | dopamine receptor D3 | 400 aa | 392 aa | 19.9 % |
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 497 aa | 425 aa | 32.0 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Leishmania major | cytochrome p450-like protein | cytochrome P450, family 2, subfamily C, polypeptide 19 | 490 aa | 411 aa | 23.1 % |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.5457 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 138 Cyp138 | 0.0021 | 0.1897 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 | 0.0021 | 0.1897 | 0.1897 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0032 | 0.3757 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0045 | 0.5972 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 128 Cyp128 | 0.0021 | 0.1897 | 0.5 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 125 Cyp125 | 0.0021 | 0.1897 | 0.5 |
Trypanosoma brucei | cytochrome P450, putative | 0.0032 | 0.3757 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0032 | 0.3757 | 0.3757 |
Brugia malayi | Cytochrome P450 family protein | 0.0021 | 0.1897 | 0.1551 |
Mycobacterium tuberculosis | Probable cytochrome P450 144 Cyp144 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | 0.0021 | 0.1897 | 0.5 |
Brugia malayi | cytochrome P450 | 0.0021 | 0.1897 | 0.1551 |
Leishmania major | cytochrome p450-like protein | 0.0032 | 0.3757 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 143 Cyp143 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Cytochrome P450 121 Cyp121 | 0.0021 | 0.1897 | 0.5 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.5457 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0021 | 0.1897 | 0.5 |
Mycobacterium leprae | putative cytochrome p450 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 132 Cyp132 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 139 Cyp139 | 0.0021 | 0.1897 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.6692 | 1 |
Mycobacterium tuberculosis | Possible cytochrome P450 135A1 Cyp135A1 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Possible cytochrome P450 126 Cyp126 | 0.0021 | 0.1897 | 0.5 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0032 | 0.3757 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0032 | 0.3757 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.6692 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0032 | 0.3757 | 0.3757 |
Mycobacterium tuberculosis | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) | 0.0021 | 0.1897 | 0.5 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0045 | 0.5972 | 0.58 |
Mycobacterium tuberculosis | Probable cytochrome P450 123 Cyp123 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 137 Cyp137 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Possible cytochrome P450 135B1 Cyp135B1 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 130 Cyp130 | 0.0021 | 0.1897 | 0.5 |
Echinococcus multilocularis | 0.0021 | 0.1897 | 0.2675 | |
Brugia malayi | Cytochrome P450 family protein | 0.0032 | 0.3757 | 0.3491 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.1897 | 0.2368 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0045 | 0.5972 | 0.5972 |
Mycobacterium tuberculosis | Probable cytochrome P450 140 Cyp140 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 monooxygenase 142 Cyp142 | 0.0021 | 0.1897 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0409 | 0.0409 |
Brugia malayi | Cytochrome P450 family protein | 0.0032 | 0.3757 | 0.3491 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0032 | 0.3757 | 0.3757 |
Schistosoma mansoni | cytochrome P450 | 0.0021 | 0.1897 | 0.2368 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.4938 | 0.4938 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0067 | 1 | 1 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0045 | 0.5972 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 141 Cyp141 | 0.0021 | 0.1897 | 0.5 |
Mycobacterium tuberculosis | Probable cytochrome P450 124 Cyp124 | 0.0021 | 0.1897 | 0.5 |
Echinococcus granulosus | cytochrome P450 2K1 | 0.0021 | 0.1897 | 0.2675 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 5.12 | Inhibition of human ERG transfected in HEK293 cells assessed as reduction in tail current by patch clamp assay | LITERATURE. | 27564135 |
IC50 (ADMET) | > 7 uM | Inhibition of human CYP1A2 expressed in microsomes using ER as substrate after 10 mins by P450 cypex assay | LITERATURE. | 27564135 |
IC50 (ADMET) | > 7 uM | Inhibition of human CYP2C19 expressed in microsomes using BMC as substrate after 10 mins by P450 cypex assay | LITERATURE. | 27564135 |
IC50 (ADMET) | > 7 uM | Inhibition of human CYP3A4 expressed in microsomes using DEF as substrate after 10 mins by P450 cypex assay | LITERATURE. | 27564135 |
IC50 (ADMET) | > 7 uM | Inhibition of human CYP2C9 expressed in microsomes using FCA as substrate after 10 mins by P450 cypex assay | LITERATURE. | 27564135 |
IC50 (ADMET) | > 7 uM | Inhibition of human CYP2D6 expressed in microsomes using MMC as substrate after 10 mins by P450 cypex assay | LITERATURE. | 27564135 |
Ki (binding) | = 6.33 | Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting | LITERATURE. | 27564135 |
Ki (binding) | = 9.07 | Displacement of [3H]-spiperone from human dopamine D3 receptor expressed in CHO-K1 cell membranes after 90 mins by liquid scintillation counting | LITERATURE. | 27564135 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.